Number of Stent Retriever Passes Associated with Clinical Outcome After Mechanical Thrombectomy in Acute Ischemic Stroke

J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105199. doi: 10.1016/j.jstrokecerebrovasdis.2020.105199. Epub 2020 Aug 20.

Abstract

Objective: To evaluate the association between the number of stent retriever (SR) passes and clinical outcome after mechanical thrombectomy (MT) in patients with acute ischemic stroke(AIS).

Methods: We retrospectively analyze data collected from consecutive patients with large vessel occlusion (LVO) in anterior circulation treated with MT. Baseline characteristics, number of SR passes, symptomatic intracranial hemorrhage (sICH), clinical outcome measured by modified Rankin Scale (mRS) at 90 days after MT were collected. Multivariate logistic regression analysis was performed to assess the association between number of SR passes and patients' clinical outcome.

Results: 134 patients with LVO achieved successful reperfusion (mTICI 2B/3) were enrolled. Univariate analysis showed that patients with favorable outcomes were less likely to need more than three passes of SR (9.8%vs39.7%, p = 0.001). In a multivariable analysis, baseline NIHSS score (OR 0.922, 95%CI 0.859∼0.990, p = 0.025), more than three passes of SR (OR 0.284, 95%CI0.091∼0.882, p = 0.030) and symptomatic intracranial hemorrhage (OR 0.116,95%CI0.021∼0.650, p = 0.014) each independently predicted poor outcome after MT at 90 days.

Conclusion: The need for more than three passes of SR may be used as an independent predictor of poor outcome after MT in patients with acute ischemic stroke at 90 days.

Keywords: Mechanical thrombectomy; Outcome; Reperfusion; Stroke.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Brain Ischemia / diagnostic imaging
  • Brain Ischemia / physiopathology
  • Brain Ischemia / therapy*
  • Disability Evaluation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Recovery of Function
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Stents*
  • Stroke / diagnostic imaging
  • Stroke / physiopathology
  • Stroke / therapy*
  • Thrombectomy / adverse effects
  • Thrombectomy / instrumentation*
  • Time Factors
  • Treatment Outcome